AVI-4020: Phase I/II updated data

Updated data from a placebo-controlled U.S. Phase I/II trial in 10 patients showed AVI-4020 had an elimination half-life of 4-5 hours. AVI-4020 was detected in cerebrospinal fluid (CSF) of all 9 patie...